Stay updated on CP-690,550 Dose Comparison in RA Clinical Trial
Sign up to get notified when there's something new on the CP-690,550 Dose Comparison in RA Clinical Trial page.

Latest updates to the CP-690,550 Dose Comparison in RA Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check20 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.5%
- Check28 days agoChange DetectedThe web page has removed a specific citation regarding a study on Creatine Kinase levels in Tofacitinib-treated patients with Ulcerative Colitis, including an erratum reference.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page has removed a citation regarding the efficacy and safety of tofacitinib, including an erratum reference.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
Stay in the know with updates to CP-690,550 Dose Comparison in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CP-690,550 Dose Comparison in RA Clinical Trial page.